Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study


OBJECTIVE To evaluate the effects of oral delayed-release dimethyl fumarate (DMF; also known as gastro-resistant DMF) on MRI lesion activity and load, atrophy, and magnetization transfer ratio (MTR) measures from the Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis (CONFIRM) study. METHODS CONFIRM was a 2-year, placebo-controlled… (More)
DOI: 10.1212/WNL.0000000000001360


4 Figures and Tables


Citations per Year

134 Citations

Semantic Scholar estimates that this publication has 134 citations based on the available data.

See our FAQ for additional information.